Literature DB >> 26191321

Malignant melanoma mimicking giant cell variant of glioblastoma multiforme: a case report and review of literature.

Ramir Arcega1, William H Yong1, Haodong Xu1.   

Abstract

We present a case of metastatic malignant melanoma in a patient initially diagnosed with glioblastoma multiforme, giant cell variant. A forty year old female presented to our institution for a re-resection of a recurrent right parietal lobe mass, presumed to be recurrent glioblastoma multiforme. PET scan during preoperative evaluation revealed a 3 cm left lower lobe lung mass. Metastatic glioblastoma to lung was considered in the differential diagnosis. Resection of the brain mass revealed a highly pleomorphic giant and spindle cell lesion with an immunophenotype strongly supportive of melanoma. Immunostains for melanocytic markers were subsequently performed on the lung biopsy specimen, and demonstrated diffuse staining of the atypical cells, supporting the diagnosis of malignant melanoma in the lung. This case demonstrates the importance of considering melanoma in the differential in any tumor with high grade features.

Entities:  

Keywords:  Melanoma; giant cell variant glioblastoma multiforme; pleormorphic lung carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26191321      PMCID: PMC4503192     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

1.  Aberrant neurofilament protein and synaptophysin expression in malignant melanoma of the nasal cavity.

Authors:  A Coli; P G Giacomini; G Bigotti; S Ferraro; M Alessandrini; M Del Vecchio; G Massi
Journal:  Histopathology       Date:  2004-02       Impact factor: 5.087

2.  Intrathecal dacarbazine treatment of leptomeningeal malignant melanoma.

Authors:  M A Champagne; H K Silver
Journal:  J Natl Cancer Inst       Date:  1992-08-05       Impact factor: 13.506

3.  Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study.

Authors:  B F Cole; R D Gelber; J M Kirkwood; A Goldhirsch; E Barylak; E Borden
Journal:  J Clin Oncol       Date:  1996-10       Impact factor: 44.544

4.  Malignant monstrocellular brain tumours. A study of 42 surgically treated cases.

Authors:  L Palma; P Celli; A Maleci; N Di Lorenzo; G Cantore
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

5.  Metastatic pattern of malignant melanoma. A study of 216 autopsy cases.

Authors:  J K Patel; M S Didolkar; J W Pickren; R H Moore
Journal:  Am J Surg       Date:  1978-06       Impact factor: 2.565

Review 6.  Morphological and immunophenotypic variations in malignant melanoma.

Authors:  S S Banerjee; M Harris
Journal:  Histopathology       Date:  2000-05       Impact factor: 5.087

Review 7.  Demographics of brain metastasis.

Authors:  J D Johnson; B Young
Journal:  Neurosurg Clin N Am       Date:  1996-07       Impact factor: 2.509

Review 8.  The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.

Authors:  Naoki Shinojima; Masato Kochi; Jun-ichiro Hamada; Hideo Nakamura; Shigetoshi Yano; Keishi Makino; Hiromasa Tsuiki; Kenji Tada; Jun-ichi Kuratsu; Yasuji Ishimaru; Yukitaka Ushio
Journal:  J Neurosurg       Date:  2004-08       Impact factor: 5.115

9.  Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.

Authors:  Sanjiv S Agarwala; John M Kirkwood; Martin Gore; Brigitte Dreno; Nicholas Thatcher; Beate Czarnetski; Michael Atkins; Antonio Buzaid; Dimosthenis Skarlos; Elaine M Rankin
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

10.  Lung metastases from melanoma: when is surgical treatment warranted?

Authors:  F Leo; L Cagini; P Rocmans; M Cappello; A N Geel; G Maggi; P Goldstraw; U Pastorino
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.